An open-source high-content analysis workflow for CFTR function measurements using the forskolin-induced swelling assay

MOTIVATION The forskolin-induced swelling (FIS) assay has become the preferential assay to predict the efficacy of approved and investigational CFTR-modulating drugs for individuals with cystic fibrosis (CF). Currently, no standardized quantification method of FIS data exists thereby hampering inter-laboratory reproducibility. RESULTS We developed a complete open-source workflow for standardized high-content analysis of CFTR function measurements in intestinal organoids using raw microscopy images as input. The workflow includes tools for (i) file and metadata handling; (ii) image quantification and (iii) statistical analysis. Our workflow reproduced results generated by published proprietary analysis protocols and enables standardized CFTR function measurements in CF organoids. AVAILABILITY All workflow components are open-source and freely available: the htmrenamer R package for file handling https://github.com/hmbotelho/htmrenamer; CellProfiler and ImageJ analysis scripts/pipelines https://github.com/hmbotelho/FIS_image_analysis; the Organoid Analyst application for statistical analysis https://github.com/hmbotelho/organoid_analyst; detailed usage instructions and a demonstration dataset https://github.com/hmbotelho/FIS_analysis. Distributed under GPL v3.0. SUPPLEMENTARY INFORMATION Supplementary information and a stepwise guide for software installation and data analysis for training purposes are available at Bioinformatics online.

[1]  L. Tsui,et al.  Erratum: Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA , 1989, Science.

[2]  Timothy Kassis,et al.  OrgaQuant: Human Intestinal Organoid Localization and Quantification Using Deep Convolutional Neural Networks , 2019, Scientific Reports.

[3]  Hans Clevers,et al.  Automated brightfield morphometry of 3D organoid populations by OrganoSeg , 2017, Scientific Reports.

[4]  Quantitative Phenotypic Image Analysis of Three-Dimensional Organotypic Cultures. , 2017, Methods in molecular biology.

[5]  S. Freedman,et al.  Cystic fibrosis , 2009, The Lancet.

[6]  H. Erfle,et al.  High-throughput RNAi screening by time-lapse imaging of live human cells , 2006, Nature Methods.

[7]  Iris A. L. Silva,et al.  Protocol for Application, Standardization and Validation of the Forskolin-Induced Swelling Assay in Cystic Fibrosis Human Colon Organoids , 2020, STAR protocols.

[8]  C. Teneback,et al.  Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial , 2019, The Lancet.

[9]  Matthias Griese,et al.  A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. , 2011, The New England journal of medicine.

[10]  E. Ingenito,et al.  Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del , 2017, The New England journal of medicine.

[11]  H. Oppelaar,et al.  Stratifying infants with cystic fibrosis for disease severity using intestinal organoid swelling as a biomarker of CFTR function , 2018, European Respiratory Journal.

[12]  H. Clevers,et al.  Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients. , 2017, Journal of visualized experiments : JoVE.

[13]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[14]  L. Lands,et al.  Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele. , 2019, The New England journal of medicine.

[15]  Hans Clevers,et al.  A functional CFTR assay using primary cystic fibrosis intestinal organoids , 2013, Nature Medicine.

[16]  C. Rueden,et al.  Metadata matters: access to image data in the real world , 2010, The Journal of cell biology.

[17]  Jyrki Lötjönen,et al.  Quantification of Dynamic Morphological Drug Responses in 3D Organotypic Cell Cultures by Automated Image Analysis , 2014, PloS one.

[18]  Anne E Carpenter,et al.  CellProfiler: image analysis software for identifying and quantifying cell phenotypes , 2006, Genome Biology.

[19]  H. Clevers,et al.  Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis , 2016, Science Translational Medicine.

[20]  M. Amaral,et al.  Progress in therapies for cystic fibrosis. , 2016, The Lancet. Respiratory medicine.

[21]  Toshio Takahashi,et al.  Organoids for Drug Discovery and Personalized Medicine. , 2019, Annual review of pharmacology and toxicology.

[22]  Iris A. L. Silva,et al.  Organoids as a personalized medicine tool for ultra-rare mutations in cystic fibrosis: The case of S955P and 1717-2A > G. , 2020, Biochimica et biophysica acta. Molecular basis of disease.

[23]  Chris Allan,et al.  OME Remote Objects (OMERO): a flexible, model-driven data management system for experimental biology , 2012, Nature Methods.

[24]  Gerard J. P. van Westen,et al.  High-Throughput Phenotypic Screening of Kinase Inhibitors to Identify Drug Targets for Polycystic Kidney Disease , 2017, SLAS discovery : advancing life sciences R & D.

[25]  J. Wallenburg,et al.  CFTR modulator theratyping: Current status, gaps and future directions. , 2019, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[26]  T. Hasan,et al.  Comprehensive high-throughput image analysis for therapeutic efficacy of architecturally complex heterotypic organoids , 2017, Scientific Reports.

[27]  Hans Clevers,et al.  Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. , 2011, Gastroenterology.

[28]  Xiaohong Huang,et al.  Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR. , 2015, The New England journal of medicine.